Skip to main content
Drug bottle and Pill

Compare Otezla vs. Humira

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Otezla (apremilast) and Humira (adalimumab) are both medications used to treat plaque psoriasis and psoriatic arthritis, but they have some important differences. Otezla is a phosphodiesterase-4 (PDE-4) inhibitor taken by mouth twice daily, while Humira is a biologic disease-modifying antirheumatic drug (DMARD) injected under the skin, usually every other week. Otezla is also approved for mouth sores from Behçet’s disease, whereas Humira is used for a wider range of autoimmune conditions, including rheumatoid arthritis, Crohn's disease, and ulcerative colitis. Otezla requires a gradual increase in dosage to minimize side effects like nausea and diarrhea. Generic versions of Otezla are FDA-approved but not yet available, whereas Humira has several biosimilars. Common side effects of Otezla include diarrhea and nausea, while Humira can cause injection-site reactions and increase the risk of infections. Additionally, Humira may raise the risk of lymphoma and skin cancer and cannot be used with live vaccines.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.